Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement

Autor: Claudia Fiorina, Gianmichele Migaleddu, Marco L. Rossi, Bernhard Reimers, A. Sonia Petronio, Ciro Indolfi, Carmen Spaccarotella, Giovanni Orlandi, Alaide Chieffo, Riccardo Liga, Mirco Cosottini, Marco De Carlo, Francesco De Caro, Melania Scatturin
Přispěvatelé: De Carlo, M., Liga, R., Migaleddu, G., Scatturin, M., Spaccarotella, C., Fiorina, C., Orlandi, G., De Caro, F., Rossi, M. L., Chieffo, A., Indolfi, C., Reimers, B., Cosottini, M., Petronio, A. S.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
neurocognitive function
Male
Time Factors
Databases
Factual

medicine.medical_treatment
030204 cardiovascular system & hematology
Neuropsychological Tests
0302 clinical medicine
Cognition
Valve replacement
Risk Factors
80 and over
030212 general & internal medicine
Prospective Studies
Aged
80 and over

Neurocognitive Disorder
medicine.diagnostic_test
silent cerebral ischemic lesions
Magnetic Resonance Imaging
silent cerebral ischemic lesion
Natural history
medicine.anatomical_structure
Treatment Outcome
Intracranial Embolism
Italy
Cardiology
cerebral magnetic resonance imaging
transcatheter aortic valve replacement
Aged
Aortic Valve Stenosis
Asymptomatic Diseases
Female
Humans
Neurocognitive Disorders
Risk Assessment
Transcatheter Aortic Valve Replacement
Neuropsychological Test
Cardiology and Cardiovascular Medicine
Human
medicine.medical_specialty
Transcatheter aortic
Time Factor
White matter
03 medical and health sciences
Databases
Cerebral embolism
Internal medicine
medicine
Clinical significance
Factual
Asymptomatic Disease
business.industry
Risk Factor
Magnetic resonance imaging
Aortic Valve Stenosi
Prospective Studie
business
Neurocognitive
Popis: Objectives The aim of this study was to assess the characteristics, predictors, evolution, and neurocognitive effects of silent cerebral ischemic lesions (SCILs). Background Most patients undergoing transcatheter aortic valve replacement (TAVR) develop SCILs detectable on magnetic resonance imaging (MRI). The natural history and clinical relevance of SCILs are not well established. Methods Cerebral MRI was performed within 7 days before TAVR to assess baseline status and age-related white matter change score. MRI was repeated post-operatively to assess the occurrence, location, number, and dimensions of SCILs. Patients developing SCILs underwent a third MRI examination at 3- to 5-month follow-up. A neurocognitive evaluation was performed before TAVR, at discharge, and at 3-month follow-up. Results Of the 117 patients enrolled, 96 underwent post-procedural MRI; SCILs were observed in 76% of patients, distributed in all vascular territories, with a median number of 2 lesions, a median diameter of 4.5 mm, and a median total volume of 140 mm3. Independent predictors of SCIL occurrence were higher baseline age-related white matter change score and the use of self-expanding or mechanically expanded bioprostheses. Among 47 patients who underwent follow-up MRI, only 26.7% of post-procedural SCILs evolved into gliotic scar. SCIL occurrence was associated with a more pronounced transient neurocognitive decline early after TAVR and with lower recovery at follow-up. Conclusions SCILs occur in the vast majority of patients undergoing TAVR and are predicted by more diffuse white matter damage at baseline and by the use of non-balloon-expandable prostheses. Although most SCILs disappear within months, their occurrence has a limited but significant impact on neurocognitive function.
Databáze: OpenAIRE